UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex

Scientific reports, 2021-07, Vol.11 (1), p.14283-14283, Article 14283

2021

Volltextzugriff (PDF)

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

Acta neuropathologica communications, 2019-03, Vol.7 (1), p.45-9, Article 45

2019

Volltextzugriff (PDF)

Author Correction: A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex

Scientific reports, 2022-08, Vol.12 (1), p.14171-14171, Article 14171

2022

Volltextzugriff (PDF)

Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Journal of Virology, 2009-09, Vol.83 (18), p.9094-9101

2009

Volltextzugriff (PDF)

Response to the Letter from Garcia-Montojo and colleagues concerning our paper entitled, Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

Acta neuropathologica communications, 2019-07, Vol.7 (1), p.102-102, Article 102

2019

Volltextzugriff (PDF)

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure

Antiviral research, 2014-05, Vol.105, p.112-117

2014

Volltextzugriff (PDF)

Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1806-1809

2011

Volltextzugriff (PDF)

Immunization with an Interferon-γ–gp120 Fusion Protein Induces Enhanced Immune Responses to Human Immunodeficiency Virus gp120

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1423-1430

2001

Volltextzugriff (PDF)

An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming

Vaccine, 2005-06, Vol.23 (30), p.3984-3990

2005

Volltextzugriff (PDF)

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays

AIDS (London), 2010-07, Vol.24 (11), p.1651-1655

2010

Volltextzugriff (PDF)

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5′UTR

Journal of clinical virology, 2015-05, Vol.66, p.56-59

2015

Volltextzugriff (PDF)

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5'UTR

Journal of clinical virology, 2015-05, Vol.66, p.56-59

2015

Volltextzugriff (PDF)

Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1-4

Antiviral therapy, 2015, Vol.20 (1), p.81-85

2015

Volltextzugriff (PDF)

The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypes

AIDS (London), 2014-07, Vol.28 (11), p.1611-1617

2014

Volltextzugriff (PDF)

Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients

Antiviral therapy, 2015-01, Vol.20 (3), p.361-363

2015

Volltextzugriff (PDF)

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting

Journal of acquired immune deficiency syndromes (1999), 2010-06, Vol.54 (2), p.215-216

2010

Volltextzugriff (PDF)

A potent adjuvant effect of CD40 antibody attached to antigen

Immunology, 2003-05, Vol.109 (1), p.87-92

2003

Volltextzugriff (PDF)

CD40 antibody as an adjuvant induces enhanced T cell responses

Vaccine, 2004-09, Vol.22 (25), p.3323-3328

2004

Volltextzugriff (PDF)

An interferon gamma-gp 120 fusion delivered as a DNA vaccine induces enhanced priming

Vaccine, 2005, Vol.23 (30), p.3984-3990

2005

Volltextzugriff (PDF)

Immunization with an interferon-(gamma)-gp120 fusion protein induces enhanced immune responses to Human Immunodeficiency Virus gp120

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1423

2001

Volltextzugriff (PDF)

Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination

Biochemical Society transactions, 1997-05, Vol.25 (2), p.297S-297S

1997

Volltextzugriff (PDF)

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

PloS one, 2015-09, Vol.10 (9), p.e0137834-e0137834

2015

Volltextzugriff (PDF)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa

AIDS research and human retroviruses, 2015-10, Vol.31 (10), p.1032-1037

2015

Volltextzugriff (PDF)

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

The Journal of infectious diseases, 2010-01, Vol.201 (1), p.106-113

2010

Volltextzugriff (PDF)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA

BMC infectious diseases, 2014-05, Vol.14 (S4), p.O25-O25, Article O25

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Humans
(16)
Biological And Medical Sciences
(10)
Female
(10)
Immunology
(10)
Infectious Diseases
(10)
Virology
(10)
Animals
(7)
Human Immunodeficiency Virus
(7)
Human Immunodeficiency Virus 1
(7)
Medical Sciences
(7)
Microbiology
(7)
Drug Resistance, Viral - Genetics
(6)
Hiv
(6)
Human Viral Diseases
(6)
Mice
(6)
Mutation
(6)
Viral Diseases
(6)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

Author Correction: A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex

Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1

Response to the Letter from Garcia-Montojo and colleagues concerning our paper entitled, Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure

Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1

Immunization with an Interferon-γ–gp120 Fusion Protein Induces Enhanced Immune Responses to Human Immunodeficiency Virus gp120

An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5′UTR

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5'UTR

Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1-4

The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypes

Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting

A potent adjuvant effect of CD40 antibody attached to antigen

CD40 antibody as an adjuvant induces enhanced T cell responses

An interferon gamma-gp 120 fusion delivered as a DNA vaccine induces enhanced priming

Immunization with an interferon-(gamma)-gp120 fusion protein induces enhanced immune responses to Human Immunodeficiency Virus gp120

Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa

Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine-Lamivudine plus Nevirapine and Zidovudine-Lamivudine plus Abacavir

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA

Suchergebnisse filtern